Abstract
Sir,
Systemic sclerosis (scleroderma, SSc) is an uncommon heterogeneous connective tissue disease considered to have an autoimmune origin.1 Cancer occurs more commonly in scleroderma2 and we have previously documented acquired genetic damage at the glycophorin-A locus suggesting genomic instability.
Systemic sclerosis (scleroderma, SSc) is an uncommon heterogeneous connective tissue disease considered to have an autoimmune origin.1 Cancer occurs more commonly in scleroderma2 and we have previously documented acquired genetic damage at the glycophorin-A locus suggesting genomic instability.
Original language | English |
---|---|
Pages (from-to) | 131-133 |
Number of pages | 3 |
Journal | Pathology |
Volume | 54 |
Issue number | 1 |
DOIs | |
Publication status | Published - Feb 2022 |
Externally published | Yes |
Keywords
- scleroderma
- chromosomal damage
- Systemic sclerosis
- peripheral blood lymphocytes (PBL)
- cytokinesis-block micronucleus cytome (CBMN-cyt)
- genomic instability